These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19372090)

  • 1. Update on dual antiplatelet therapy for percutaneous coronary intervention.
    Prasad A; Holmes DR
    Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment].
    Saidi Y; Guesmi F; Landolsi M; Trabelsi S; Khemiri K; Ounalli K; Dziri C; Houissa M
    Tunis Med; 2010 Jan; 88(1):63-4. PubMed ID: 20419882
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?
    Wiviott SD
    Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in responsiveness to oral antiplatelet therapy.
    Angiolillo DJ
    Am J Cardiol; 2009 Feb; 103(3 Suppl):27A-34A. PubMed ID: 19166710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
    Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
    EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
    Kamphuisen PW
    Eur Heart J; 2008 Jul; 29(14):1699-700. PubMed ID: 18544543
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversation with an expert. Plavix: what you need to know.
    O'Gara P
    Harv Heart Lett; 2011 Jan; 21(5):3. PubMed ID: 21322911
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery.
    Mahla E; Metzler H; Tantry US; Gurbel PA
    Ann Thorac Surg; 2010 Sep; 90(3):1040-51. PubMed ID: 20732553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 18. [After coronary intervention. Which platelet inhibitor for whom?].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
    [No Abstract]   [Full Text] [Related]  

  • 19. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resistance to antiplatelet substances--a real clinical problem].
    Geisler T; Gawaz M
    Herz; 2008 Jun; 33(4):260-8. PubMed ID: 18581075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.